MedTrace Logo

Allergy Delabeling in Antibiotic Stewardship - Intervention

NCT07133074 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3800

Last updated 2026-04-22

No results posted yet for this study

Summary

The overall goal of the RENEW-IN intervention is to assess the impact of a BL allergy delabeling intervention on antibiotic use and clinical outcomes in patients with a hematologic malignancy.

Conditions

  • Beta Lactam Allergy
  • Hematologic Malignancy

Interventions

DIAGNOSTIC_TEST

RENEW-IN Algorithm for assessment of a beta-lactam intervention

The RENEW-IN intervention includes a detailed assessment of the participant's beta-lactam allergy history and determination of a risk-level for allergy-delabeling.

OTHER

EMR Review

Electronic medical record review for comparative analysis

Sponsors & Collaborators

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-20
Primary Completion
2028-11-30
Completion
2029-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07133074 on ClinicalTrials.gov